In collaboration with Roche, we expect results from the Phase 2b PADOVA clinical trial evaluating prasinezumab ... enrolled approximately 260 patients in the ASCENT clinical trials Poster presentation ...
In collaboration with Roche, we expect results from the Phase 2b PADOVA clinical trial evaluating prasinezumab for Parkinson’s disease in 4Q 2024 and with Novo Nordisk, we expect results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback